Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Feb 13:12:615-625.
doi: 10.2147/COPD.S124041. eCollection 2017.

Can we predict the prognosis of COPD with a routine blood test?

Wei Xiong  1 , Mei Xu  2 , Yunfeng Zhao  3 , Xueling Wu  4 , Bigyan Pudasaini  1 , Jin-Ming Liu  1
Affiliations
Multicenter Study

Can we predict the prognosis of COPD with a routine blood test?

Wei Xiong et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Background: The major characteristic of COPD is systemic inflammation. The parameters such as neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-basophil ratio (EBR) in routine blood test (RBT) are considered to be the underlying biomarkers of inflammation. We hypothesized that the prognosis of patients with COPD can be predicted with RBT.

Methods: Patients with COPD in stable stage were enrolled. The RBT, pulmonary function testing (PFT), BODE index, C-reactive protein (CRP), procalcitonin, and erythrocyte sedimentation rate (ESR) were performed at enrollment and every follow-up once in every 3 months during the 24-month follow-up period. Meanwhile, exacerbation count and mortality incidence were recorded. The correlation between the prognostic biomarkers and the prognosis of patients was analyzed.

Results: The NLR and EBR in RBT have a significant correlation with the severity of patients with COPD. The NLR is an independent predictor for mortality and the EBR is an independent predictor for exacerbation.

Conclusion: As an inexpensive, accessible, and convenient assay, RBT may be used as a practical means in the prediction of prognosis of patients with COPD in future clinical settings.

Keywords: COPD; eosinophil-to-basophil ratio; inflammation; neutrophil-to-lymphocyte ratio; prognosis; routine blood test.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Enrollment, screening, and follow-up. Abbreviations: CRP, C-reactive protein; PFT, pulmonary function testing; RBT, routine blood test.
Figure 2
Figure 2
Receiver operating characteristic (ROC) curve of NLR for the prediction of mortality (left); ROC curve of EBR for the prediction of mortality (right). Abbreviations: AUC, area under the curve; CI, confidence interval; EBR, eosinophil-to-basophil ratio; NLR, neutrophil-to-lymphocyte ratio.
Figure 3
Figure 3
Comparison of survival rate between high NLR group and low NLR group (left); comparison of exacerbation rate between high NLR group and low NLR group (right). Notes: ○, high NLR group; ●, low NLR group. Abbreviation: NLR, neutrophil-to-lymphocyte ratio.
Figure 4
Figure 4
Comparison of survival rate between high EBR group and low EBR group (left); comparison of exacerbation rate between high EBR group and low EBR group (right). Notes: ○, low EBR group; ●, high EBR group. Abbreviation: EBR, eosinophil-to-basophil ratio.
See this image and copyright information in PMC

References

    1. Woodruff PG, Agusti A, Roche N, et al. Current concepts in targeting COPD pharmacotherapy: making progress towards personalized management. Lancet. 2015;385(9979):1789–1798. - PMC - PubMed
    1. Wain LV, Shrine N, Miller S, et al. UK Brain Expression Consortium (UKBEC) OxGSK Consortium Novel insights into the genetics of smoking behavior, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med. 2015;3(10):769–781. - PMC - PubMed
    1. Vogelmeier C, Hederer B, Glaab T, et al. POET-COPD Investigators Tiotropium versus Salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011;364(12):1093–1103. - PubMed
    1. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med. 2005;352(19):1967–1976. - PubMed
    1. Lee SJ, Lee HR, Lee TW, et al. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study. Kor J Intern Med. 2016;31(5):891–898. - PMC - PubMed

Publication types

MeSH terms